PHARM 360 Pharmacology Exam 9 – 130+ Exam Questions and Verified Answers on Antibiotics, Antivirals, Antifungals, HIV Medications & Infectious Disease Pharmacology

This comprehensive PHARM 360 Exam 9 pharmacology study guide contains more than 130 updated exam questions and verified answers focused on infectious disease pharmacology, antibiotics, antivirals, antifungals, antitubercular drugs, HIV medications, and antimicrobial therapy. The resource provides detailed NCLEX-style review questions covering bacterial classification, antiviral drug mechanisms, antifungal medications, antibiotic adverse effects, HIV treatment regimens, tuberculosis therapy, urinary tract infection treatment, and patient education for antimicrobial medications. The document thoroughly reviews essential pharmacologic principles related to antimicrobial therapy including gram staining, nucleoside analog antiviral drugs, reverse transcriptase inhibitors, neuraminidase inhibitors, nucleic acid inhibitors, integrase inhibitors, bacteriostatic antibiotics, and cell wall synthesis inhibitors. Key medications discussed include acyclovir, efavirenz, oseltamivir, ciprofloxacin, trimethoprim-sulfamethoxazole, nystatin, amphotericin B, vancomycin, tetracycline, doxycycline, rifampin, isoniazid, cephalexin, amoxicillin/clavulanic acid, raltegravir, gentamicin, polymyxin B, and fluconazole. Students will strengthen understanding of medication mechanisms of action, microbial resistance, contraindications, toxicities, and clinical applications associated with infectious disease treatment. The study guide also provides clinically relevant nursing considerations involving renal toxicity from amphotericin B, ototoxicity associated with aminoglycosides, red man syndrome caused by vancomycin, QT interval prolongation risks with fluconazole, disulfiram-like reactions with cephalosporins and alcohol, photosensitivity linked to tetracyclines, pyridoxine supplementation with isoniazid therapy, and hydration requirements during acyclovir treatment. Additional topics include HIV management using highly active antiretroviral therapy (HAART), fungal infections caused by Tinea species, and antimicrobial safety considerations in patients with penicillin allergy or myasthenia gravis. This study material aligns closely with concepts presented in: Lilley, L. L., Rainforth Collins, S., & Snyder, J. S. (2024). Pharmacology and the Nursing Process. Lehne, R. A. (2023). Lehne’s Pharmacology for Nursing Care. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s The Pharmacological Basis of Therapeutics. Centers for Disease Control and Prevention (CDC) antimicrobial stewardship and infectious disease treatment guidelines. Infectious Diseases Society of America (IDSA) recommendations for antimicrobial therapy and HIV treatment protocols. This resource is especially valuable for: Nursing pharmacology students BSN nursing students ADN nursing students Infectious disease pharmacology courses Medical-surgical nursing students NCLEX-RN pharmacology preparation Antimicrobial therapy review HIV and infectious disease nursing coursework Advanced pharmacology learners Healthcare students studying antibiotics and antivirals Keywords: PHARM 360, pharmacology exam 9, infectious disease pharmacology, antibiotics, antivirals, antifungals, antimicrobial therapy, acyclovir, nucleoside analogues, efavirenz, reverse transcriptase inhibitors, oseltamivir, neuraminidase inhibitors, ciprofloxacin, trimethoprim sulfamethoxazole, nystatin, amphotericin B, vancomycin, tetracycline, doxycycline, rifampin, isoniazid, raltegravir, integrase inhibitors, HIV medications, HAART therapy, cephalosporins, amoxicillin clavulanic acid, penicillin allergy, aminoglycosides, ototoxicity, nephrotoxicity, red man syndrome, fluconazole, antifungal drugs, tuberculosis medications, bacterial infections, viral infections, NCLEX pharmacology review, nursing pharmacology